Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean V Tavtigian

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Human Mutation|May 28, 2011
Comparison of programs for in silico assessment of missense substitutionsSean V Tavtigian
American Journal of Human Genetics|January 8, 2003
Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancerNicola J Camp, Sean V Tavtigian
Biomarkers in Medicine|May 7, 2014
Growing recognition of the role for rare missense substitutions in breast cancer susceptibilitySean V Tavtigian, Georgia Chenevix-Trench
Nature Reviews. Genetics|February 2, 2011
Tests of association for rare variants: case control mutation screeningSean V Tavtigian, Mia Hashibe, Alun Thomas
Breast Cancer Research : BCR|July 10, 2007
Identification of women with an increased risk of developing radiation-induced breast cancerElisabeth Cardis, Janet Hall, Sean V Tavtigian
Breast Cancer Research : BCR|November 14, 2006
International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'Sean V Tavtigian, Marco A Pierotti, Anne-Lise Børresen-Dale
The Journal of Pathology|December 26, 2018
Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicineLaura Valle, Eduardo Vilar, Sean V Tavtigian, et al.
Familial Cancer|March 11, 2006
An analysis of unclassified missense substitutions in human BRCA1Sean V Tavtigian, Paul B Samollow, Deepika de Silva, et al.
Human Mutation|October 28, 2008
In silico analysis of missense substitutions using sequence-alignment based methodsSean V Tavtigian, Marc S Greenblatt, Fabienne Lesueur, et al.
Human Mutation|October 28, 2008
Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working GroupSean V Tavtigian, Marc S Greenblatt, David E Goldgar, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Human Mutation|May 28, 2011
Comparison of programs for in silico assessment of missense substitutionsSean V Tavtigian
American Journal of Human Genetics|January 8, 2003
Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancerNicola J Camp, Sean V Tavtigian
Biomarkers in Medicine|May 7, 2014
Growing recognition of the role for rare missense substitutions in breast cancer susceptibilitySean V Tavtigian, Georgia Chenevix-Trench
Nature Reviews. Genetics|February 2, 2011
Tests of association for rare variants: case control mutation screeningSean V Tavtigian, Mia Hashibe, Alun Thomas
Breast Cancer Research : BCR|July 10, 2007
Identification of women with an increased risk of developing radiation-induced breast cancerElisabeth Cardis, Janet Hall, Sean V Tavtigian
Breast Cancer Research : BCR|November 14, 2006
International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'Sean V Tavtigian, Marco A Pierotti, Anne-Lise Børresen-Dale
The Journal of Pathology|December 26, 2018
Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicineLaura Valle, Eduardo Vilar, Sean V Tavtigian, et al.
Familial Cancer|March 11, 2006
An analysis of unclassified missense substitutions in human BRCA1Sean V Tavtigian, Paul B Samollow, Deepika de Silva, et al.
Human Mutation|October 28, 2008
In silico analysis of missense substitutions using sequence-alignment based methodsSean V Tavtigian, Marc S Greenblatt, Fabienne Lesueur, et al.
Human Mutation|October 28, 2008
Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working GroupSean V Tavtigian, Marc S Greenblatt, David E Goldgar, et al.
Pageof 13